Beacon Biosignals
Boston
About Beacon Biosignals
Beacon Biosignals is a neurotechnology company focused on bringing precision neuroscience into clinical trials and treatments for brain- and sleep-related disorders. The company’s core offering includes an FDA-cleared wearable device (the Waveband headband) that captures high-fidelity EEG during sleep and wake states, combined with an AI-driven analytics platform that processes millions of hours of neural data to extract biomarkers of brain function. Its end-to-end solution supports pharmaceutical and biotech clients by providing tools for patient stratification, dose-response monitoring, and early-stage disease progression, enabling trials to be more precise and efficient.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $116.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Nov 2025)
- Website: beacon.bio
- Phone: 401-225-5782
Industries & Categories
Artificial Intelligence (AI), Health Care, Health Diagnostics, Machine Learning, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/beacon-biosignals-113602 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.